Asset-like acquisitions

Similar documents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K/A

Consolidated Statement of Profit or Loss (in million Euro)

Consolidated Statement of Profit or Loss (in million Euro)

CBI - 10th Life Sciences Accounting and Reporting Congress. March 18, 2014

AGILENT TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (In millions, except per share amounts) (Unaudited)

Non-GAAP Information 5/3/2018

FLEX RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (In thousands, except per share amounts)

AGILENT TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (In millions, except per share amounts) (Unaudited)

ON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share data)

Coherent, Inc. Consolidated Statement of Operations - GAAP

Updated to reflect new accounting policy changes and quarterly presentation on Television business reported as discontinued operations.

December 31, 2017 January 1, 2017

GILAT SATELLITE NETWORKS LTD. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS U.S. dollars in thousands (except share and per share data)

LUPIN INC. AND SUBSIDIARIES. Consolidated Financial Statements As of and for the Years Ended March 31, 2018 and 2017

Non-GAAP Definitions Masimo

1Q Performance Summary

UNISYS CORPORATION CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (Millions, except per share data)

ON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS (in millions, except per share data)

First Half of 2015 Performance Summary

ON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share data)

Track Group Reports Fiscal 2017 Financial Results

Non-GAAP Financial Measures. Third Quarter and First Nine Months of Fiscal

Current Developments New GAAP Requirements and Effect on Accounting for Income Taxes

First Quarter 2016 Performance Summary

Financial Section. P. 44 Consolidated Balance Sheet. P. 46 Consolidated Statement of Income. P. 47 Consolidated Statement of Comprehensive Income

Documents Glossary of IP Terms/Financial

January 26, 2016 Media Contact: Dan Turner WILMINGTON, Del Investor Contact:

Coherent, Inc. Consolidated Statement of Operations - GAAP

First Quarter 2017 Earnings Results

Exhibit F. Financial Projections

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q

Q Financial information

TENNANT COMPANY (Exact name of registrant as specified in its charter)

Coherent, Inc. Consolidated Statement of Operations - GAAP

Non-GAAP Financial Measures Fourth Quarter and Fiscal 2009

Reynolds Group Holdings Limited

Understanding Financial Statements and Their Effects on Enhancing Value

ACCO Brands Corporation Fourth Quarter 2008 Earnings Call. February 27, 2009

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 10-Q

Non-GAAP Financial Measures Second Quarter and First Half of Fiscal 2010

Fourth Quarter 2015 Performance Summary

IQVIA Reports Third-Quarter 2018 Results and Updates Full-Year 2018 Guidance

Non-GAAP Financial Measures

New Japan Radio Co., Ltd. and Consolidated Subsidiaries

GOODWILL IMPAIRMENT TESTING Comparison of IFRS v GAAP

Financial and Non-financial Highlights Financial Section Consolidated Balance Sheet

Q Earnings Call. May 3, 2016

Life Sciences Accounting and Financial Reporting Update Interpretive Guidance on Revenue Recognition Under ASC 606

Mylan: Q EARNINGS August 8, Q Earnings All Results are Unaudited

Fourth Quarter 2016 Performance Summary

October 27, 2015 Media Contact: Dan Turner WILMINGTON, Del Investor Contact:

Recurring revenue 36, , % Non recurring revenue 3, , %

McGraw-Hill Education, Inc. Quarterly Report. As of March 31, 2017

ON Semiconductor Reports Fourth Quarter and 2018 Annual Results

TEIKOKU ELECTRIC MFG. CO., LTD. Consolidated Financial Statements for the Year Ended March 31, 2016 and Independent Auditor's Report

TENNANT COMPANY (Exact name of registrant as specified in its charter)

Third Quarter Earnings November 8, 2018

SECOND QUARTER 2017 EARNINGS RELEASE July 20, 2017

Third Quarter 2016 Performance Summary

Consolidated Balance Sheets Consolidated Statements of Income...4. Consolidated Statements of Changes in Equity...5 6

Masonite International Corporation Reports 2017 First Quarter Financial Results

NEW JAPAN RADIO CO., LTD. For the fiscal year 2009, ended March 31, 2010

CONSOLIDATED BALANCE SHEET AND INCOME STATEMENT DECEMBER 31, 2012

CISCO SYSTEMS, INC. (Exact name of registrant as specified in its charter)

VALUATION OF GOODWILL WITHIN THE FAMILY LAW CONTEXT

CSG SYSTEMS INTERNATIONAL, INC. DISCLOSURES FOR NON-GAAP FINANCIAL MEASURES

Endo Health Solutions

Conference Call Brooks Automation First Quarter FY19 Financial Results. February 5, 2019

Net sales $ 106, % $ 77, %$ 29, % Legacy business 82, , , Acquired business 24,

Recro Pharma, Inc. (Exact name of registrant as specified in its charter)

CSP Inc. (Exact name of Registrant as specified in its charter)

Mylan Q Non-GAAP Reconciliations November 5, Q Earnings All Results are Unaudited

AgroFresh Business Combination Summary

Valuation of Intangible Assets including. Purchase Price Allocation :74. Purchase Price Allocation

ON Semiconductor Reports Third Quarter 2018 Results

Fourth Quarter Results Fiscal Year 2018

Q Financial information 1 Q FINANCIAL INFORMATION

SL Bidco B.V. Interim financial report for the period 1 January 30 June Table of contents

Momentive Performance Materials Inc. 22 Corporate Woods Blvd. Albany, NY 12211

ITURAN LOCATION AND CONTROL LTD. Consolidated Interim Financial Statements as of March 31, 2014

Accretive Solutions Q Quarterly Learning Series. Due Diligence Best Practices

The J. M. Smucker Company

BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter)

ON Semiconductor Reports Fourth Quarter and 2017 Annual Results

ITURAN LOCATION AND CONTROL LTD. Consolidated Interim Financial Statements as of March 31, 2013

Intertape Polymer Group Reports 2018 Second Quarter Results

International Glossary of Business Valuation Terms

Bottomline Technologies Reconciliation to Non GAAP Measures Three Months Ended June 30, 2013

ation erials nt Mat ese Pr or lementalestvin Supp

Houghton Mifflin Harcourt Company Consolidated Balance Sheets

Reynolds Group Holdings Limited

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q. For the quarterly period ended September 30, 2018

FORM 6-K. CGG (Translation of registrant s name into English)

Mylan Q EARNINGS November 5, Q Earnings All Results are Unaudited

The Stephan Co. Fourth Quarter Report December 31, 2017 Page 1

One of the major applications of Equity Valuation is the Private companies valuation. Private companies valuation can be applied:

Transfer Pricing and Business Restructurings

FLEX RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

Management s Disucussion and Analysis

Net sales $267.3 $258.2 $524.0 $507.3 Cost of goods sold Gross profit

Transcription:

Asset-like acquisitions Valuation considerations 17 March 2015

Asset-like acquisitions What do we mean by an Asset-like acquisition? An acquisition of a product or group of products that meets the definition of a business and recorded as a business combination pursuant to ASC 805.but, goodwill is NOT anticipated as the forecasts do not include revenue or earnings from unidentified future products How is the expectation of minimal/no goodwill achieved in an asset-like acquisition? Page 2

Asset-like acquisitions Taxable transaction (Asset deal) Buyer receives stepped-up tax basis on asset and presumably pays for this within the agreed upon price Book to tax differences are minimal as are potential deferred taxes Non-taxable transaction (Stock deal) Buyer does not receive a stepped-up tax basis and presumably pays less as no tax shield is available Book to tax differences are substantial as are potential deferred taxes Page 3

Asset-like acquisitions Example: Purchase of Developed technology for $50M Opening balance sheet - Taxable Transaction Opening balance sheet - Non-taxable Transaction Assets Assets Developed Technology 50 Developed Technology 50 Economic? Goodwill 0 Goodwill 15 Total Assets 50 Total Assets 65 Liabilities Liabilities DTL 0 DTL 15 Equity 50 Equity 50 Total Liabilities & Equity 50 Total Liabilities & Equity 65 Page 4

Day 2 issues & challenges Valuation considerations 17 March 2015

Day 2 issues & challenges Goodwill impairment Reporting unit versus IPR&D testing dates Interim testing procedures Cost structure in PPA versus cost structure in impairment analysis Allocation of corporate costs Changes to cash flows forecasts prior to initial test date Measurement period adjustment or potential impairment Discount rates Size and company specific risk premiums IPR&D impairment Testing based on therapeutic area, geography, launch date, etc. Change of indication for existing IPR&D product Milestones/royalties related to prior acquisitions versus licenses Cost structure in PPA versus cost structure in impairment analysis Capital asset charges post acquisition Page 6

Day 2 issues & challenges Sources of goodwill Future technology/customers Synergies not attributable to intangible assets Sale of a business operation (carve out) Allocation of existing goodwill Contingent consideration Methodology Discount rate Page 7

Tax synergies Purchase price allocation Tax structuring (e.g. NOLs, IP migration, inversions) has become a more common aspect of the deals in recent years. The benefits of the tax structuring are typically considered (i.e. modeled out) in deal models and become a new source of synergy. Tax synergies considerations in purchase price allocation Inversion deals or inverted companies - typically modeled out as the tax benefit resulting from shielding of the US profits (generally the buyer s profits) by an inter-company loan set up to finance the deal Typically considered market-participant assumption if explicitly included in the deal model (in other words, something the buyer paid for ) There is a debate whether tax synergies should be included in the intangible asset valuations when these are driven by the tax structure of the buyer as opposed to deal structure Page 8

Tax synergies Purchase price allocation In inversion deals, unlike operating synergies, tax synergies are not assumed to be part of the asset valuation as realization of these synergies would not be possible outside an inversion deal structure, which is a stock deal As a result, the value of tax synergies is typically carved out of the deal model and overall purchase price is split into the operating value and tax synergies Since the tax synergies assumptions are not included in the valuation of intangible assets, its value ends up in goodwill Page 9

Tax synergies Goodwill allocation and impairment test Initial goodwill allocation Because goodwill is assigned to the reporting units that are expected to benefit from the synergies of the combination, it is possible that the acquirer may assign a portion of the goodwill related to tax synergies to its own reporting units In the case of multiple reporting units, relative pre-tax profit or EBIT may be a reasonable allocation methodology Goodwill impairment test Incorporating tax synergies in Day 2 valuations of the reporting units present a modeling challenge Extending initial model assumptions (i.e., refinancing or incremental leverage assumptions) Assigning the benefit of future tax optimization strategies to the individual reporting unit models Page 10

Day 2 issues & challenges GAAP vs Non GAAP adjustments Amortization of inventory step up Stock-based compensation expense Impairment of goodwill and intangibles Acquisition, integration and restructuring expenses Amortization of intangible assets Upfront and development milestone costs Contingent consideration fair value adjustments Non-recurring expenses Legal expenses Impact of currency fluctuations Adjust tax expense to cash taxes Page 11

Inventory Valuation considerations 17 March 2015

Inventory introduction Inventory is comprised of several different categories: Ready to be sold in the normal course of business (finished goods) In production for future sale (work-in-process or WIP) Used in the production of goods to be sold (raw materials) Valuation classification may differ from accounting or balance sheet classification. In certain cases (e.g. outsourced manufacturing, API is classified as raw materials on the balance sheet but would be treated as work in process in the valuation and stepped-up because value has been added in the manufacturing of the API) Page 13

Inventory valuation introduction The fair values for work-in-process (WIP) and finished goods inventory acquired in a business combination are generally measured using a net realizable value computation. The net realizable value computation takes the expected sales price of the inventory reduced for all costs expected to be incurred in the completion and disposition of the inventory as well as a profit on those costs. Raw materials at current replacement cost The size of the inventory step up is directly correlated to the profitability of the business/product over the period over which the inventory is expected to be disposed of Page 14

Inventory valuation process Estimate selling price Gross up method versus bottom-up build up Estimate costs to complete and disposition costs Inclusion of indirect operating expenses or disposition costs (e.g. G&A to support manufacturing or sales functions) Inclusion of R&D expenses and royalties Estimate profit on the remaining costs Identification of expenses and efforts for which the seller is not generally entitled to a profit (e.g. 3 rd party royalties) Normalized profit versus profit over the expected period of inventory disposition Page 15

Inventory additional valuation considerations Pre-approval inventory in the life sciences industry, inventory acquired before a therapy is approved is often expensed to R&D. If the target is acquired shortly after the therapy has been approved, expensed inventory that is expected to be sold will need to be fair valued. Outsourced manufacturing while the book value of inventory for companies that outsource their manufacturing process may represent the arm s length price for the contract manufacturing services, it does not reflect the value of the intellectual property inherent in the product. Therefore, inventory manufactured by a contract manufacturer will typically be stepped-up to the extent any IP is relied upon in the manufacturing process/ resulting product. Page 16

Inventory additional valuation considerations Large amount of acquired inventory typical in large molecule/ biotechnology therapeutics where the amount of acquired inventory is expected to last several years after the acquisition, in extreme cases, throughout the expected life of the corresponding intangible asset. The inventory valuation in this case will look more akin to intangible asset valuation with expected profit attributable to the incurred costs to be discounted at rates close to intangible asset discount rate. Royalty charges technology royalty is applied in the WIP calculations to represent hypothetical royalty a third party would need to incur for access to the intellectual property in order to complete the inventory Page 17

Inventory step-up in intangible assets valuation When valuing intangible assets acquired in a business combination where there is also an inventory step-up, the profit included in the inventory step-up must be removed from the projected financial information of the intangible asset so that the profit is not recognized more than once. The full amount of the inventory step-up must be removed from the projections of the intangible asset over the time period in which the acquired inventory is expected to turn. Page 18

Inventory step-up in technology asset valuation - example Step-up adjustment included Remove total inventory stepup from gross profit over the expected period of inventory For the years ending 31 Dec disposition (USD in 000s) 2015E 2016E 2017E 2018E 2019E Revenue associated with technology 100,000 110,000 121,000 133,100 146,410 Cost of goods sold (20,000) (22,000) (24,200) (26,620) (29,282) Inventory step up (10,000) (11,000) (12,100) (13,310) - Gross profit 70,000 77,000 84,700 93,170 117,128 SG&A (25,000) (27,500) (30,250) (33,275) (36,603) Research and development (8,000) (7,750) (1,314) (986) (986) EBITDA 37,000 41,750 53,136 58,909 79,540 Depreciation (tax) (40) (110) (185) (258) (341) Pretax income (loss) 36,960 41,640 52,952 58,651 79,199 Income tax expense (13,860) (15,615) (19,857) (21,994) (29,700) Net income (loss) 23,100 26,025 33,095 36,657 49,499 Add: Depreciation (tax) 40 110 185 258 341 Less: Return of fixed assets (40) (110) (185) (258) (341) Less: Contributory assets' charge (357) (392) (431) (475) (1,044) After-tax cash flow 22,743 25,633 32,663 36,183 48,455 Present value factor 11.0% 0.9327 0.8403 0.7570 0.6820 0.6144 Present value of after-tax cash flow 21,214 21,539 24,727 24,677 29,772 Present value discrete cash flows 329,923 Remove expected inventory sales price from the revenue base used to calculate contributory asset charges Page 19

Inventory step-up in technology asset valuation - example Step-up adjustment excluded For the years ending 31 Dec (USD in 000s) 2015E 2016E 2017E 2018E 2019E Revenue associated with technology 100,000 110,000 121,000 133,100 146,410 Cost of goods sold (20,000) (22,000) (24,200) (26,620) (29,282) Inventory step up - - - - - Gross profit 80,000 88,000 96,800 106,480 117,128 SG&A (25,000) (27,500) (30,250) (33,275) (36,603) Research and development (8,000) (7,750) (1,314) (986) (986) EBITDA 47,000 52,750 65,236 72,219 79,540 Depreciation (tax) (40) (110) (185) (258) (341) Pretax income (loss) 46,960 52,640 65,052 71,961 79,199 Income tax expense (17,610) (19,740) (24,394) (26,986) (29,700) Net income (loss) 29,350 32,900 40,657 44,976 49,499 Add: Depreciation (tax) 40 110 185 258 341 Less: Return of fixed assets (40) (110) (185) (258) (341) Less: Contributory assets' charge (713) (784) (863) (949) (1,044) After-tax cash flow 28,637 32,115 39,794 44,027 48,455 Present value factor 11.0% 0.9327 0.8403 0.7570 0.6820 0.6144 Present value of after-tax cash flow 26,711 26,987 30,126 30,027 29,772 Present value discrete cash flows 351,616 Page 20